Cynthia A Zahnow

Cynthia A Zahnow

UNVERIFIED PROFILE

Are you Cynthia A Zahnow?   Register this Author

Register author
Cynthia A Zahnow

Cynthia A Zahnow

Publications by authors named "Cynthia A Zahnow"

Are you Cynthia A Zahnow?   Register this Author

35Publications

493Reads

Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma.

Oncotarget 2018 Apr 10;9(27):19379-19395. Epub 2018 Apr 10.

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

View Article
April 2018

Chemotherapy induces enrichment of CD47/CD73/PDL1 immune evasive triple-negative breast cancer cells.

Proc Natl Acad Sci U S A 2018 02 24;115(6):E1239-E1248. Epub 2018 Jan 24.

McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205;

View Article
February 2018

DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk.

Cancer Cell 2018 02;33(2):309-321.e5

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:

View Article
February 2018

Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.

Cancer Cell 2017 09;32(3):360-376.e6

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:

View Article
September 2017

Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.

Mol Oncol 2017 05 6;11(5):552-566. Epub 2017 Apr 6.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article
May 2017

CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes.

Cancer Cell 2017 05;31(5):653-668.e7

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address:

View Article
May 2017

Combining Epigenetic and Immunotherapy to Combat Cancer.

Cancer Res 2016 Apr 17;76(7):1683-9. Epub 2016 Mar 17.

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article
April 2016

A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis.

Genes Dev 2014 Mar;28(5):432-7

Department of Molecular Biology and Genetics, Howard Hughes Medical Institute.

View Article
March 2014

Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.

PLoS One 2013 3;8(7):e68630. Epub 2013 Jul 3.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

View Article
February 2014

The future of epigenetic therapy in solid tumours--lessons from the past.

Nat Rev Clin Oncol 2013 May 2;10(5):256-66. Epub 2013 Apr 2.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287, USA.

View Article
May 2013

LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.

Mol Cancer 2011 Aug 19;10:100. Epub 2011 Aug 19.

Department of Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

View Article
August 2011

Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.

Blood 2011 Jun 29;117(23):6297-303. Epub 2011 Mar 29.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article
June 2011

Epigenetic networks and miRNAs in stem cells and cancer.

Mol Cell 2010 Sep;39(5):661-3

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical, Institutions, Baltimore, MD 21231, USA.

View Article
September 2010

CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.

Authors:
Cynthia A Zahnow

Expert Rev Mol Med 2009 Apr 8;11:e12. Epub 2009 Apr 8.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting-Blaustein Cancer Research Building, 1650 Orleans St, Baltimore, MD 21231-1000, USA.

View Article
April 2009

A histological survey of green fluorescent protein expression in 'green' mice: implications for stem cell research.

Pathology 2007 Apr;39(2):247-51

Epithelial Stem Cell Working Group, Department of Surgery, Sidney Kimmel Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, USA.

View Article
April 2007

ErbB receptors and their ligands in the breast.

Authors:
Cynthia A Zahnow

Expert Rev Mol Med 2006 Sep 20;8(23):1-21. Epub 2006 Sep 20.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting-Blaustein Cancer Research Building, 1650 Orleans St, Baltimore, MD 21231-1000, USA.

View Article
September 2006

Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.

Mol Cell Biol 2004 May;24(9):3682-91

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

View Article
May 2004

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

Cell 2003 Aug;114(3):323-34

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article
August 2003

CCAAT/enhancer binding proteins in normal mammary development and breast cancer.

Authors:
Cynthia A Zahnow

Breast Cancer Res 2002 19;4(3):113-21. Epub 2002 Apr 19.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

View Article
June 2002